1 – 10 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2025 Update
- Contribution to journal › Debate/Note/Editorial
-
Mark
Peritoneal recurrence following nephrectomy for localized renal cancer : A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study–UroCCR 124)
(2025) In Urologic Oncology: Seminars and Original Investigations
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
- Contribution to journal › Article
- 2023
-
Mark
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer
- Contribution to journal › Scientific review
-
Mark
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
- Contribution to journal › Article
- 2022
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2022 Update
- Contribution to journal › Scientific review
-
Mark
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
- Contribution to journal › Article
-
Mark
Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
- Contribution to journal › Article
- 2021
-
Mark
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
- Contribution to journal › Article
-
Mark
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium
- Contribution to journal › Article